{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:52:23Z","timestamp":1753890743345,"version":"3.41.2"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Major advancements are expected in medicine and healthcare in the 21st century- \u201cDigital Age\u201d, mainly due to the application of data technologies and artificial intelligence into healthcare. In this perspective article we share a short story depicting the future Cushings\u2019 Disease patient and the postulated diagnostic and management approaches. In the discussion, we explain the advances in recent times which makes this future state plausible. We postulate that endocrinology care will be completely reinvented in the Digital Age.<\/jats:p>","DOI":"10.3389\/fendo.2022.943993","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T17:21:56Z","timestamp":1657128116000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cushing\u2019s Disease Management: Glimpse Into 2051"],"prefix":"10.3389","volume":"13","author":[{"given":"Rinkoo","family":"Dalan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan R.","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard O.","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41746-022-00583-z","article-title":"Digital Biomarkers: Convergence of Digital Health Technologies and Biomarkers","volume":"5","author":"Vasudevan","year":"2022","journal-title":"NPJ Digit Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/s21165589","article-title":"Review of Wearable Devices and Data Collection Considerations for Connected Health","volume":"21","author":"Vijayan","year":"2021","journal-title":"Sensors (Basel)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1109\/RBME.2022.3141877","article-title":"Advances in non-Invasive Blood Pressure Measurement Techniques","author":"Panula","year":"2022","journal-title":"IEEE Rev BioMed Eng"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000087","article-title":"Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association","volume":"73","author":"Muntner","year":"2019","journal-title":"Hypertension"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-73172-3","article-title":"Comparing Blood Pressure Measurements Between a Photoplethysmography-Based and a Standard Cuff-Based Manometry Device","volume":"10","author":"Nachman","year":"2020","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2337\/cd17-0130","article-title":"Freestyle Libre Glucose Monitoring System","volume":"36","author":"Blum","year":"2018","journal-title":"Clin Diabetes"},{"key":"B7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/dia.2018.0150","article-title":"Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults With Diabetes","volume":"20","author":"Wadwa","year":"2018","journal-title":"Diabetes Technol Ther"},{"article-title":"Ascensia Diabetes Care Announces Fda Approval of the Eversense E3 Continuous Glucose Monitoring System for Use for Up to 6 Months","volume-title":"Ascensia Diabetes Care","year":"","key":"B8"},{"key":"B9","article-title":"Endocrine Testing Protocols: Hypothalamic Pituitary Adrenal Axis","volume-title":"TABLE I, Methods Available for Measurement of Serum or Plasma Cortisol","author":"J.Yeo","year":""},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2017.07.035","article-title":"Direct Analysis - No Sample Preparation - of Bioavailable Cortisol in Human Plasma by Weak Affinity Chromatography (WAC)","author":"Ohlson","year":"2017","journal-title":"J Chromatogr B Analyt Technol BioMed Life Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31829daa0a","article-title":"The Detection of Cortisol in Human Sweat: Implications for Measurement of Cortisol in Hair","volume":"36","author":"Russell","year":"2014","journal-title":"Ther Drug Monit"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.831831","article-title":"Diurnal Salivary Cortisol in Relation to Body Composition and Heart Rate Variability in Young Adults","volume":"13","author":"Cvijetic","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s43246-020-00114-x","article-title":"Extended Gate Field-Effect-Transistor for Sensing Cortisol Stress Hormone","volume":"2","author":"Sheibani","year":"2021","journal-title":"Commun Mater"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb2891","article-title":"Smart, Soft Contact Lens for Wireless Immunosensing of Cortisol","volume":"6","author":"Ku","year":"2020","journal-title":"Sci Adv"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.matt.2020.01.021","article-title":"Investigation of Cortisol Dynamics in Human Sweat Using a Graphene-Based Wireless Mhealth System","volume":"2","author":"Torrente-Rodr\u00edguez","year":"2020","journal-title":"Matter"},{"key":"B16","doi-asserted-by":"publisher","first-page":"112782","DOI":"10.1016\/j.bios.2020.112782","article-title":"Battery-Free, Wireless, and Flexible Electrochemical Patch for in Situ Analysis of Sweat Cortisol via Near Field Communication","volume":"172","author":"Cheng","year":"2021","journal-title":"Biosens Bioelectron"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abk0967","article-title":"Wearable Aptamer-Field-Effect Transistor Sensing System for Noninvasive Cortisol Monitoring","volume":"8","author":"Wang","year":"2022","journal-title":"Sci Adv"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1994.tb00097.x","article-title":"The Basophil Adenomas of the Pituitary Body and Their Clinical Manifestations (Pituitary Basophilism)","volume":"50","author":"Cushing","year":"1932","journal-title":"Bull Johns Hopkins Hosp"},{"volume-title":"The Pituitary Body and its Disorders: Clinical States Produced by Disorders of the Hypophysis Cerebri","year":"1912","author":"Cushing","key":"B19"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2002.97.1.0231","article-title":"Cushing's Case XLV: Minnie G","volume":"97","author":"Lanzino","year":"2002","journal-title":"J Neurosurg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2022.02.001","article-title":"Consensus Statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on Diagnosis of Cushing's Syndrome","volume":"83","author":"Tabarin","year":"2022","journal-title":"Ann Endocrinol (Paris)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2022.03.076","article-title":"MRI-Negative Cushing's Disease: A Review on Therapeutic Management","author":"Sabahi","year":"2022","journal-title":"World Neurosurg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20210732","article-title":"Superiority of Endoscopic Transsphenoidal Pituitary Surgery to Microscopic Transseptal Pituitary Surgery for Treatment of Cushing's Disease","volume":"67","author":"Zhang","year":"2021","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.3171\/2014.10.FOCUS14700","article-title":"Cushing's Disease: Current Medical Therapies and Molecular Insights Guiding Future Therapies","volume":"38","author":"Lau","year":"2015","journal-title":"Neurosurg Focus"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-992813","article-title":"Circadian Blood Pressure Profile in Patients With Active Cushing's Disease and After Long-Term Cure","volume":"39","author":"Pecori Giraldi","year":"2007","journal-title":"Horm Metab Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","article-title":"The Hypertension of Cushing's Syndrome: Controversies in the Pathophysiology and Focus on Cardiovascular Complications","volume":"33","author":"Isidori","year":"2015","journal-title":"J Hypertens"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1159\/000345905","article-title":"Decreased Autonomic Modulation of Heart Rate and Altered Cardiac Sympathovagal Balance in Patients With Cushing's Syndrome: Role of Endogenous Hypercortisolism","volume":"97","author":"Chandran","year":"2013","journal-title":"Neuroendocrinology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3666692","article-title":"The Beta-Cell Function and Glucose Profile of Newly Diagnosed Acromegalic Patients With Normal Glucose Tolerance","volume":"2021","author":"Sun","year":"2021","journal-title":"Int J Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0354","article-title":"Metabolic Comorbidities in Cushing's Syndrome","volume":"173","author":"Ferra\u00f9","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0272","article-title":"Subclinical Hypercortisolism: A State, a Syndrome, or a Disease","volume":"173","author":"Di Dalmazi","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.75.3.1517373","article-title":"Preclinical Cushing's Syndrome in Adrenal \"Incidentalomas\": Comparison With Adrenal Cushing's Syndrome","volume":"75","author":"Reincke","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02247","article-title":"Corticotropin-Releasing Hormone Physiology","volume":"155","author":"Majzoub","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-021-02076-0","article-title":"Endogenous Cortisol Excess Confers a Unique Lipid Signature and Metabolic Network","volume":"99","author":"Vega-Beyhart","year":"2021","journal-title":"J Mol Med (Berl)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00814","article-title":"Metabolomics-A Promising Approach to Pituitary Adenomas","volume":"9","author":"P\u00eenzariu","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13123","article-title":"Pituitary MRI in Cushing's Disease - an Update","volume":"15","author":"Bonneville","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30240-0","article-title":"LINC 3 Investigators. Efficacy and Safety of Osilodrostat in Patients With Cushing's Disease (LINC 3): A Multicentre Phase III Study With a Double-Blind, Randomised Withdrawal Phase","volume":"8","author":"Pivonello","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00009.2018","article-title":"Effect of a Melanocortin Type 2 Receptor (MC2R) Antagonist on the Corticosterone Response to Hypoxia and ACTH Stimulation in the Neonatal Rat","volume":"315","author":"Goldenberg","year":"2018","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60417","article-title":"EGFR as a Therapeutic Target for Human, Canine, and Mouse ACTH-Secreting Pituitary Adenomas","volume":"121","author":"Fukuoka","year":"2011","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-008-9080-6","article-title":"Potential of Retinoic Acid Derivatives for the Treatment of Corticotroph Pituitary Adenomas","volume":"10","author":"Labeur","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1018091108","article-title":"Targeting Zebrafish and Murine Pituitary Corticotroph Tumors With a Cyclin-Dependent Kinase (CDK) Inhibitor","volume":"108","author":"Liu","year":"2011","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1606","article-title":"Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease","volume":"100","author":"Liu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02080","article-title":"Tumor-Directed Therapeutic Targets in Cushing Disease","volume":"104","author":"Theodoropoulou","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2021-0364","article-title":"Nano-Based Targeted Drug Delivery for Lung Cancer: Therapeutic Avenues and Challenges","author":"Ezhilarasan","year":"2022","journal-title":"Nanomed (Lond)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41746-021-00418-3","article-title":"The Emerging Clinical Role of Wearables: Factors for Successful Implementation in Healthcare","volume":"4","author":"Smuck","year":"2021","journal-title":"NPJ Digit Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.943993\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T17:22:02Z","timestamp":1657128122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.943993\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":44,"alternative-id":["10.3389\/fendo.2022.943993"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.943993","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"article-number":"943993"}}